This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Yuan Lu in Gene Therapy
Introduction
Yuan Lu is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of gene therapy, particularly through his work on recombinant adeno-associated virus (rAAV) vectors. His innovative approaches have the potential to advance therapeutic techniques in genetic medicine.
Latest Patents
Yuan Lu holds a patent for "Genome-modified recombinant adeno-associated virus vectors." This patent includes recombinant adeno-associated virus nucleic acid vectors that feature modifications within at least one inverted terminal repeat (ITR) region. Notable modifications in his patent include ITR sequences that comprise a glucocorticoid responsive element and/or a transcription factor binding site. The patent also encompasses plasmids, libraries, rAAV particles, compositions, kits, and methods related to these vectors.
Career Highlights
Yuan Lu is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to explore and develop innovative solutions in the realm of gene therapy. His research has garnered attention for its potential applications in treating various genetic disorders.
Collaborations
Yuan Lu has collaborated with notable colleagues, including Chen Ling and Arun Srivastava. These partnerships have contributed to the advancement of research in gene therapy and the development of new therapeutic strategies.
Conclusion
Yuan Lu's contributions to the field of gene therapy through his innovative patent and collaborative efforts highlight his role as a key inventor in this important area of research. His work continues to pave the way for future advancements in genetic medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
